Cantor Fitzgerald’s Medtronic MDT Stock Holding History

Cantor Fitzgerald’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-227,114	Closed	-$17.8M	–	431
2023 Q3	$17.8M	Sell	227,114 -16,798	-7%	-$1.41M	0.48%	69
2023 Q2	$21.5M	Sell	243,912 -3,679	-1%	-$317K	0.49%	64
2023 Q1	$20M	Buy	247,591 +8,150	+3%	+$664K	0.42%	72
2022 Q4	$18.6M	Buy	239,441 +55,064	+30%	+$4.46M	0.4%	78
2022 Q3	$14.9M	Sell	184,377 -52,210	-22%	-$4.69M	0.33%	91
2022 Q2	$21.2M	Buy	+236,587	New	+$24M	0.41%	68

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Cantor Fitzgerald's MDT Position: Q4 2023 in Review

Cantor Fitzgerald sold out of Medtronic (MDT) in Q4 2023, closing a stake of 227,114 shares — an estimated $17.8M sold.

Cantor Fitzgerald first reported a position in MDT in Q2 2022 and held it in 6 quarters. The position peaked at $21.5M in Q2 2023. 2,077 funds tracked by Wall St. Rank hold MDT as of Q4 2023.

Cantor Fitzgerald reported no remaining Medtronic position as of Q4 2023 after selling out during the quarter.
Cantor Fitzgerald sold 227,114 Medtronic shares in Q4 2023, an estimated $17.8M.
Cantor Fitzgerald first reported a position in Medtronic in Q2 2022 and held it in 6 quarters.
Cantor Fitzgerald's Medtronic position peaked at $21.5M in Q2 2023.
2,077 funds tracked by Wall St. Rank held Medtronic as of Q4 2023.

Based on Cantor Fitzgerald's 13F filing for Q4 2023, filed 14 Feb 2024.